Literature DB >> 14727887

Statistical optimization of gastric floating system for oral controlled delivery of calcium.

S Li1, S Lin, Y W Chien, B P Daggy, H L Mirchandani.   

Abstract

The development of an optimized gastric floating drug delivery system is described. Statistical experimental design and data analysis using response surface methodology is also illustrated. A central, composite Box-Wilson design for the controlled release of calcium was used with 3 formulation variables: X1 (hydroxypropyl methylcellulose [HPMC] loading), X2 (citric acid loading), and X3 (magnesium stearate loading). Twenty formulations were prepared, and dissolution studies and floating kinetics were performed on these formulations. The dissolution data obtained were then fitted to the Power Law, and floating profiles were analyzed. Diffusion exponents obtained by Power Law were used as targeted response variables, and the constraints were placed on other response variables. All 3 formulation variables were found to be significant for the release properties (P <.05), while only HPMC loading was found to be significant for floating properties. Optimization of the formulations was achieved by applying the constrained optimization. The optimized formulation delivered calcium at the release rate of 40 mg/hr, with predicted n and T50% values at 0.93 and 3.29 hours, respectively. Experimentally, calcium was observed to release from the optimized formulation with n and T50% values of 0.89 (+/- 0.10) and 3.20 (+/- 0.21) hours, which showed an excellent agreement. The quadratic mathematical model developed could be used to further predict formulations with desirable release and floating properties.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 14727887      PMCID: PMC2750255          DOI: 10.1208/pt020101

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  16 in total

1.  A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics.

Authors:  M Ichikawa; S Watanabe; Y Miyake
Journal:  J Pharm Sci       Date:  1991-11       Impact factor: 3.534

2.  Calcium bioavailability.

Authors:  R P Heaney
Journal:  Bol Asoc Med P R       Date:  1987-01

3.  Computer optimization of pharmaceutical formulations. I. General procedure.

Authors:  J B Schwartz; J R Flamholz; R H Press
Journal:  J Pharm Sci       Date:  1973-07       Impact factor: 3.534

4.  The cutoff size for gastric emptying of dosage forms.

Authors:  J Timmermans; A J Moës
Journal:  J Pharm Sci       Date:  1993-08       Impact factor: 3.534

5.  Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid.

Authors:  B C Thanoo; M C Sunny; A Jayakrishnan
Journal:  J Pharm Pharmacol       Date:  1993-01       Impact factor: 3.765

Review 6.  Calcium bioavailability and absorption: a review.

Authors:  L H Allen
Journal:  Am J Clin Nutr       Date:  1982-04       Impact factor: 7.045

7.  The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol.

Authors:  M Oth; M Franz; J Timmermans; A Möes
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

8.  Meal-feeding and phosphorus ingestion influence calcium bioavailability evaluated by calcium balance and bone breaking strength in pigs.

Authors:  A Pointillart; L Guéguen
Journal:  Bone Miner       Date:  1993-04

9.  [Development of gentamicin sulfate sustained release tablet remaining-floating in stomach].

Authors:  W L Xu; X D Tu; Z D Lu
Journal:  Yao Xue Xue Bao       Date:  1991

Review 10.  Gastroretentive dosage forms.

Authors:  A J Moës
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1993       Impact factor: 4.889

View more
  11 in total

Review 1.  Floating drug delivery systems: a review.

Authors:  Shweta Arora; Javed Ali; Alka Ahuja; Roop K Khar; Sanjula Baboota
Journal:  AAPS PharmSciTech       Date:  2005-10-19       Impact factor: 3.246

2.  Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection.

Authors:  Atul C Badhan; Rajashree C Mashru; Punit P Shah; Arti R Thakkar; Nitin B Dobaria
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

Review 3.  Different methodologies for sustainability of optimization techniques used in submerged and solid state fermentation.

Authors:  Anup Ashok; Devarai Santhosh Kumar
Journal:  3 Biotech       Date:  2017-09-07       Impact factor: 2.406

4.  Response surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage form.

Authors:  A Palamakula; Mohammad T H Nutan; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2004-04-26       Impact factor: 3.246

5.  Preparation and evaluation of diltiazem hydrochloride-Gelucire 43/01 floating granules prepared by melt granulation.

Authors:  Shyam Shimpi; Bhaskar Chauhan; K R Mahadik; Anant Paradkar
Journal:  AAPS PharmSciTech       Date:  2004-07-12       Impact factor: 3.246

6.  Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium.

Authors:  Meena Rani; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2004-08-20       Impact factor: 3.246

7.  Prolonged intragastric drug delivery mediated by Eudragit® E-carrageenan polyelectrolyte matrix tablets.

Authors:  Ahmad Bani-Jaber; Leena Al-Aani; Hatim Alkhatib; Bashar Al-Khalidi
Journal:  AAPS PharmSciTech       Date:  2011-02-08       Impact factor: 3.246

8.  Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design.

Authors:  Dasharath M Patel; Natavarlal M Patel; Viral F Patel; Darshini A Bhatt
Journal:  AAPS PharmSciTech       Date:  2007-04-13       Impact factor: 3.246

9.  Design and optimization of floating drug delivery system of acyclovir.

Authors:  A A Kharia; S N Hiremath; A K Singhai; L K Omray; S K Jain
Journal:  Indian J Pharm Sci       Date:  2010-09       Impact factor: 0.975

10.  Optimization of Paclitaxel Containing pH-Sensitive Liposomes By 3 Factor, 3 Level Box-Behnken Design.

Authors:  Smita Rane; Bala Prabhakar
Journal:  Indian J Pharm Sci       Date:  2013-07       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.